InsiderClue
← All stocks

Denali Therapeutics Inc.

DNLI Net selling
CIK 0001714899 #1526 in the set updated 17 Sep 2026
Bought (120 mo)
$4.95M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$467.90M
$6.64M on a plan · $28.04M straight out of an exercise
Sold at will
$433.22M
387 of 501 sales
Net
−$462.95M
−$428.27M against sales at will

By person

22 insiders · 516 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BRATTON DOUGLAS K
10% owner
$4.95M (1)
$335.63M (19)
−$330.68M
9,984,836
6.25%
$222.56M
+3,095%
Watts Ryan J.
President and CEO
—
$41.18M (122)
−$41.18M
2,417,217
1.51%
$53.88M
−19.2%
Tessier-Lavigne Marc
Director
—
$36.20M (40)
−$36.20M
1,965,424
1.23%
$43.81M
−28.8%
Schuth Alexander O.
COFO and Secretary
—
$18.46M (121)
−$18.46M
1,342,051
0.8396%
$29.91M
+1.1%
Krognes Steve E.
Director
—
$15.19M (37)
−$15.19M
888,202
0.5557%
$19.80M
+41.2%
Ho Carole
Chief Medical Officer
—
$11.29M (101) scheduled
−$11.29M
415,362
0.2598%
$9.26M
−5.8%
Schenkein David P
Director
—
$7.84M (7)
−$7.84M
47,897
0.0300%
$1.07M
—
SATO VICKI L
Director
—
$1.78M (50)
−$1.78M
107,976
0.0675%
$2.41M
+38.0%
Thornberry Nancy
Director
—
$261.93K (2) scheduled
−$261.93K
19,686
0.0123%
$438.80K
+944.9%
Chin Peter Scott
Chief Medical Officer
—
$36.87K (1)
−$36.87K
204,538
0.1280%
$4.56M
−0.8%
Cook Jennifer E.
Director
—
$31.68K (1) scheduled
−$31.68K
32,483
0.0203%
$724.05K
—
ARCH Venture Fund VIII, L.P. entity
10% owner
—
—
—
10,668,749
6.67%
$237.81M
+3,314%
NELSEN ROBERT
Director
—
—
—
9,681,181
6.06%
$215.79M
+2,998%
Flagship Ventures Fund V, L.P. entity
10% owner
—
—
—
8,918,749
5.58%
$198.80M
+2,754%
BAKER BROS. ADVISORS LP entity
Director
—
—
—
3,422,366
2.14%
$76.28M
+1.0%
FIL Ltd entity
See Remark 1
—
—
—
1,916,212
1.20%
$42.71M
—
FLATLEY JAY T
Director
—
—
—
363,157
0.2272%
$8.09M
+358.4%
Klein Peter S
Director
—
—
—
33,941
0.0212%
$756.54K
—
FMR LLC entity
See Remark 1
—
—
—
33,215
0.0208%
$740.36K
—
Cole Douglas G.
Director
—
—
—
26,564
0.0166%
$592.11K
+140.7%
Harris Erik
Director
—
—
—
17,052
0.0107%
$380.09K
—
Van Hauwermeiren Timothy
Director
—
—
—
17,040
0.0107%
$379.82K
—

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Ho Carole
5 Aug 2025
Chief Medical Officer
Exercised, kept
44,655
$0.68
$30.37K
Schuth Alexander O.
27 Dec 2024
COFO and Secretary
Exercised, kept
6,708
$5.28
$35.42K
Ho Carole
25 Nov 2024
Chief Medical Officer
Exercised, kept
17,845
$0.68
$12.13K
Schuth Alexander O.
22 Nov 2024
COFO and Secretary
Exercised, kept
20,516
$0.68
$13.95K
Schuth Alexander O.
8 Feb 2024
COFO and Secretary
Exercised, kept
50,000
$0.68
$34.00K
Schuth Alexander O.
7 Oct 2022
COFO and Secretary
Exercised, kept indirect
20,000
$0.68
$13.60K
Krognes Steve E.
19 Jul 2022
Director
Exercised, kept
62,500
$0.68
$42.50K
Watts Ryan J.
10 Feb 2022
President and CEO
Exercised, kept
6,118
$9.60
$58.73K
Watts Ryan J.
10 Feb 2022
President and CEO
Exercised, kept
64,631
$5.28
$341.25K
Schuth Alexander O.
20 Sep 2021
COO and Secretary
Exercised, kept
9,045
$0.68
$6.15K
Showing 250 of 516 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 397
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 68
Sales at will 387
Transactions with no price 0
Shares from compensation/vesting 63,608,485
Sales filed before the plan box existed 354
History held since 8 Dec 2017